← Return to Keytruda, an immunotherapy drug, is shrinking the Merkel Cell tumors

Discussion

Keytruda, an immunotherapy drug, is shrinking the Merkel Cell tumors

Neuroendocrine Tumors (NETs) | Last Active: Jul 25, 2023 | Replies (14)
Comment receiving replies
@mpuap

Look into adding ivermectin to your check point inhibitor. Google the research. Looks like it has the potential to enhance the therapeutic benefits of Keytruda. I’m now on both along with 5-FU/Lucovorin for stage 4 mucin producing urothelial adenocarcinoma of prostate. FOLFOX for 4 rounds with too much neuropathy from oxaliplatin. PDL1 score 100 so got coverage for Keytruda. 1 round in so stay tuned.

Jump to this post

Replies to "Look into adding ivermectin to your check point inhibitor. Google the research. Looks like it has..."
Colleen Young, Connect Director | @colleenyoung | Jul 24, 2023

Researchers are studying Ivermectin to see if it may be used as an anti-cancer drug and early studies show promise. Please note that this research is in the early stages (mice studies) and has not yet been tested in human trials. Ivermectin is not a proven standard treatment for prostate cancer.

Ivermectin combined with other chemotherapy drugs or targeted drugs is being studied in early clinical trials and shows promise in patients for whom conventional chemotherapy has not worked in some cancer types. It may be effective against drug-resistant cancer cells.

– Ivermectin, a potential anticancer drug derived from an antiparasitic drug https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505114/

@mpuap, do you have further studies showing efficacy of ivermectin with other cancer drugs? Are you on a clinical trial?

VIEW AND REPLY